Hypertension is the most common chronic medical condition in the United States, affecting nearly one-third of the adult population, 1,2 and a leading risk factor for cardiovascular disease and mortality. 3, 4 Guidelines recommend screening for hypertension by first measuring office blood pressure (BP), and then obtaining confirmatory out-of-office testing using either 24-hour ambulatory blood pressure monitoring or home blood pressure monitoring. [5] [6] [7] Misclassifying a patient as having elevated office BP can lead to inappropriate diagnostic labeling, overtreatment with antihypertensive medications, and unnecessary health care and insurance costs. [8] [9] [10] Conversely, misclassifying a patient as having nonelevated office BP may lead to undertreatment of hypertension. Despite the importance of its accurate measurement, there is no consensus among guidelines on the optimal number of readings or the best device for measuring office BP. 11, 12 Office BP measurement is used to approximate an individual's average, or usual, resting office BP, referred to here as the "true office BP. " Confirmatory factor analysis (CFA) is a statistical method that can be used to model the relationships of multiple office BP readings with the "true office BP. " 13 Thus, we developed a CFA model that enables us to compare the diagnostic accuracy of common approaches to measuring office BP including: (i) increasing the number of BP readings taken within a visit; (ii) increasing the number of office visits in which BP readings are taken; (iii) averaging 3 BP readings taken in a single visit vs. dropping the first of 3 readings and averaging the rest; and (iv) using manual vs. automatic BP devices. 14
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METHODS

Study population
We analyzed data from the 707 participants enrolled at the Stony Brook University site of the Masked Hypertension Study, a community-based study of the prevalence, predictors, and prognosis of masked hypertension. 15 Participants were recruited by conducting BP screenings for employees of
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BACKGROUND
The optimal approach to measuring office blood pressure (BP) is uncertain. We aimed to compare BP measurement protocols that differed based on numbers of readings within and between visits and by assessment method.
METHODS
We enrolled a sample of 707 employees without known hypertension or cardiovascular disease, and obtained 6 standardized BP readings during each of 3 office visits at least 1 week apart, using mercury sphygmomanometer and BpTRU oscillometric devices (18 readings per participant) for a total of 12,645 readings. We used confirmatory factor analysis to develop a model estimating "true" office BP that could be used to compare the probability of correctly classifying participants' office BP status using differing numbers and types of office BP readings.
RESULTS
Averaging 2 systolic BP readings across 2 visits correctly classified participants as having BP below or above the 140 mm
Hg threshold at least 95% of the time if the averaged reading was <134 or >149 mm Hg, respectively. Our model demonstrated that more confidence was gained by increasing the number of visits with readings than by increasing the number of readings within a visit. No clinically significant confidence was gained by dropping the first reading vs. averaging all readings, nor by measuring with a manual mercury device vs. with an automated oscillometric device.
Stony Brook University, Stony Brook University Hospital, and a small financial firm. At the time of the screening, employees were briefly told about the study. Potentially eligible employees who were interested in participating were subsequently contacted by telephone to confirm their eligibility. Those who were eligible and chose to participate were formally consented at their first study visit. The institutional review boards of Stony Brook University and Columbia University Medical Center approved all procedures for this study.
Employees were eligible if they were 18 years of age or older, spoke and read English, were employed more than 20 hours per week, worked on at least 2 consecutive days per week, were not taking a hypertension medication, and had a screening BP <160/105 mm Hg (average of second and third readings). Employees were ineligible if they self-reported a history of cardiovascular disease, or other major chronic medical condition (i.e., kidney, liver, adrenal, thyroid disorder; organ transplant; cancer not in remission more than 6 months); were prescribed antihypertensive or any other cardiovascular medications other than statins; or took any medications known to influence BP. Other exclusions included current or planned pregnancy, severe psychiatric disorder, active substance abuse, and unavailability for follow-up during the 3 months after screening. Smoking, hyperlipidemia, type II diabetes mellitus, and a past history of untreated hypertension were not exclusion criteria.
Procedure
Participants attended 4 study visits over a 4-week period. During the first 3 visits, each approximately 1 week apart, office BP was assessed using a standardized protocol in accordance with the American Heart Association's guidelines. 11 At each office visit, study personnel first confirmed that participants had not eaten, smoked, or consumed a caffeinated beverage during the prior 30 minutes. A trained nurse then measured the circumference of the participant's non-dominant arm with a Gullick II tape measure and chose the appropriately sized cuff. After the participant had been seated comfortably with their feet on the floor for at least 5 minutes, a mercury sphygmomanometer (Baum, Copiague, NY) was used to take 3 manual BP readings. The nurse waited 1-2 minutes between each reading. After the third reading, the nurse waited another 1-2 minutes and then took another 3 readings, each 2 minutes apart, using the BpTRU oscillometric device (BpTRU Medical Devices, Coquitlam, BC) on the same non-dominant arm. The nurse remained in the same room as the patient at the time of the automated readings. This protocol generated 18 office BP readings for each participant distributed across 3 visits (3 manual followed by 3 oscillometric readings per visit). Participants also completed a questionnaire that included sociodemographic characteristics. At the fourth visit, participants completed a medical history interview and had their height and weight measured in standardized fashion for calculation of body mass index.
Statistical analysis
We used CFA to model the relationships among the 18 office BP readings obtained by the sphygmomanometer and the oscillometric device ( Figure 1 ). CFA is a multivariable statistical technique used to evaluate the relationship of multiple measured variables to the underlying constructs they are presumed to represent. 16 Our CFA accounted for 4 main sources of variance among the individual BP readings. First and foremost, individuals differ in their "true office BP. " Second, office BPs measured at different visits may vary systematically from the "true office BP" due to a variety of unspecified visit-specific factors (e.g., recent salt intake, stress, emotional factors). Third, office BP readings often differ from each other (and the visit-specific "true BP") due to random "noise. " By averaging multiple office readings during a single visit, the random fluctuations between readings average out and one arrives at a better estimate of the person's "true BP" for that visit. Last, a single office BP reading may vary from the "true office BP" due to systematic upward (or downward) biases in measurement. Specifically, an alerting response found in initial readings may lead to a difference between the first and subsequent measurements, and this was explicitly incorporated into our model. [17] [18] [19] Our model yields estimates of these different sources of variance that determine the individual office BP readings. Our model also accounts for potential systematic differences between manual and automatic office BP in means and variance components.
With this conceptual model in place, we initially specified a maximally parsimonious CFA model ( Figure 1 ) in which only 6 parameters were used to model the 18 means, 18 SDs, and 153 correlations among the 9 manual and 9 automatic office BP readings. Constraints on the model were removed in a conceptually guided, step-wise manner-and the model was made increasingly complex-if lifting constraints substantially improved the fit of the model. This model was estimated by full information maximum likelihood using the M-Plus software (version 6.1; Muthén & Muthén, Los Angeles, CA) and all available data under the assumption that any missing data were missing at random. We used multiple model fit indices along with standard recommendations for defining an "acceptable" model to assess model fit (Supplementary  Tables 1 and 2 ). 20 After arriving at a parsimonious model that adequately fit the data, model estimates (Supplementary Table 3 ) were used to generate estimates of the precision with which commonly used BP measurement protocols would approximate the "true office BP. " These estimates were then used to determine the probability that office BP, measured by a given protocol, would correctly classify an individual's "true office BP" status as elevated or non-elevated using a cutpoint of 130/80 mm Hg, and separately 140/90 mm Hg. These cutpoints represent the thresholds for diagnosing stage I and stage II hypertension, respectively, as per the 2017 American College of Cardiology/American Heart Association high BP guidelines. 7 Separate CFA models were estimated for systolic and diastolic BP. SAS (version 9.4, Cary, NC) was used to generate descriptive statistics for the sample.
RESULTS
The mean (SD) age of participants was 45.4 (10.2) years. Sixty percent of participants were women, 6% were AfricanAmerican, and 7% were Hispanic (Table 1) . Of the 6,363 planned manual and automatic BP readings, there were only 0.05% and 1.23% missing data, respectively. The average manual BP at the initial visit (average of 3 manual readings) was 116/76 mm Hg. The overall average manual BP (average of 9 manual readings) was 116/75 mm Hg, and the overall average oscillometric BP was nearly identical, 115/75 mm Hg (average of 9 oscillometric readings).
Increasing the number of readings within visits and/or the number of visits
The gain in confidence obtained by increasing the number of BP measurements/visit and/or increasing the number of visits is portrayed in Figure 2 . Overall, one gained more confidence that a measured systolic BP was within 5 mm Hg of the "true" office systolic BP by increasing the number of visits as compared to increasing the number of readings within a visit. For example, when increasing the number of systolic BP readings within a single visit from 1 to 2, the likelihood that the measured systolic BP was within 5 mm Hg of the "true" office systolic BP increased by 9% for manual measurement and 7% for oscillometric measurement. In contrast, adding a second visit, again with one reading, increased the confidence by 14% for manual measurement and 16% for oscillometric measurement. There were diminishing returns from increasing the number of systolic BP readings within a visit from 2 to 3, or from increasing the number of visits from 2 to 3. For example, increasing the number of manual measurements within a single visit from 2 to 3 only increased the likelihood that the measured systolic BP was within 5 mm Hg of the "true" systolic BP by 4% for manual measurement and 3% for oscillometric measurement. The same pattern was present for diastolic BP (Supplementary Figure 1) .
Dropping the first of 3 BP readings and averaging the second and third readings
The first manual systolic BP reading was 1.3 mm Hg higher than the overall average systolic BP. Figure 2 shows the difference in probability of being within 5 mm Hg of the "true" office systolic BP for a given number of visits when dropping the first of 3 BP readings and averaging the latter 2 as compared to averaging all 3 readings. Dropping the first of 3 manual BP readings did not substantially alter the precision of classification, but there was reduced precision for oscillometric measurements. The same pattern was found for diastolic BP (see Supplementary Figure 1 ). Figure 3 shows a comparison of the probability of being within 5 or 10 mm Hg of the "true" office systolic BP when Figure 1 . Confirmatory factor analysis model of "true blood pressure" based on observed readings. The circle containing the text "Visit 1 BP man " represents the "true" average of the person's manual BP during the 5 minutes manual BP readings were being taken at a single office visit. The rectangular boxes (BP M11 , BP M12 , and BP M13 ) represent the 3 observed manual BP readings taken at Visit 1. These readings are expected to be similar to "Visit 1 BP man " as they each depend primarily on the "true" average BP during those few minutes, represented by the arrows from "Visit 1 BP man " to each box. The fact that the 3 readings are not identical is portrayed by the 3 "ε" terms representing the fluctuations of the individual readings around the "true" average, including any random measurement error in the taking of the reading. The same logic applies to repeat visits (i.e., "Visit 2 BP man " and "Visit 3 BP man "). While not agreeing perfectly, "Visit 1 BP man , " "Visit 2 BP man , " and "Visit 3 BP mal " are also expected to be highly correlated because they each depend on '"true" Manual BP; the visit-to-visit fluctuations are portrayed by λ M1 , λ M2 , and λ M3 . There is an exactly parallel model for the automatic (BpTRU) measurements. The 2 halves of the overall model are linked by curved arrows representing the following correlations: the '"true" Manual BP is very highly correlated with the "true" Automatic BP; and whatever it is that makes someone's Visit 1 manual BP deviate from their "true" manual office BP will tend to make their Visit 1 Automatic BP similarly deviate from their "true" Automatic BP (λ M1 is expected to be positively correlated with λ A1 , and similarly for λ M2 with λ A2 and λ M3 with λ A3 ). Abbreviations: auto, automatic; BP, blood pressure; man, manual.
Manual vs. oscillometric measurement
using standardized, guideline-concordant manual and oscillometric BP measurements (i.e., 2 visits, 3 readings per visit, removing the first reading of each visit and average the remaining 2 readings 11 ). The research quality manual readings were more likely (6%) to correctly classify "true" systolic BP status than the automatic readings. There was no appreciable difference between the 2 methods for diastolic BP (Supplementary Figure 2) . Figure 4 shows the probability that an average office systolic BP will correctly classify a patient's office systolic BP as elevated or non-elevated using a cutpoint of 140/90 mm Hg depending on the measurement protocol (combination of number of visits and number of readings per visit). If the average BP based on the indicated protocol is in the green zone, then the patient and clinician can be >95% confident that a diagnosis based on this average will be correct; stated differently, there is <5% chance that the true office systolic BP is on the opposite side of 140 mm Hg. If the average BP is in the yellow zone, then one's confidence that a diagnosis based on this BP is correct is 75-95%; it will be wrong 5-25% of the time. Finally, if the average is in the red zone, then a diagnosis based on the observed average will be incorrect >25% of the time. Although data for this analysis were taken from BP readings from 3 office visits, once specified, the model can provide probability estimates of correct classification based on any number of visits and readings.
Comparison of the probability of correct office BP classification according to different office BP measurement protocols
The figure shows that there is greater benefit, in terms of increasing the range of office systolic BPs with high confidence classifications (green zone), from increasing the number of visits than from increasing the number of readings per visits. For example, using a protocol with a single reading at a single visit, a systolic BP of 150 mm Hg would provide only intermediate confidence (yellow zone) that the true office systolic BP was elevated whereas using a protocol with a single reading per visit across 2 visits, a systolic BP of 150 mm Hg would provide >95% confidence that the true office systolic BP was elevated (green zone). A similar pattern was observed for office diastolic BP classification (Supplementary Figure 3) .
For patients with average measured systolic BPs closer to the 140 mm Hg cutpoint, roughly between 137 and 143 mm Hg, even a strategy of more than 3 readings across more than 3 visits would leave significant probability (>25%; red zone) that the average measured office systolic BP was on the opposite side of the cutpoint from their "true" office systolic BP. Thus, one cannot reliably classify the "true" office systolic BP status of patients with these readings, and alternative approaches to classifying BP status such as ambulatory blood pressure monitoring or home blood pressure monitoring may be needed.
We also examined the probability of correct classification using a threshold systolic BP of 130 mm Hg (Supplementary  Figure 4) . Our model shows the same pattern for the association between the measurement protocol and confidence in correct BP classification, with a greater number of readings needed to achieve >95% confidence as the BP is closer to the 130 mm Hg threshold. Similar pattern was observed using a threshold diastolic BP of 80 mm Hg (Supplementary  Figure 5) . Abbreviation: BP, blood pressure. a Blood pressure characteristics were based on the average of 3 manual readings during Visit 1. Participants who withdrew from the study prior to the fifth visit (n = 44) were missing data pertaining to body mass index, smoking status, and diabetes, and some (n = 18) were missing years of education. One participant's Visit 1 blood pressure readings were lost prior to data entry.
DISCUSSION
Guidelines and scientific statements recommend measuring BP in the office setting to identify patients with elevated BP and to monitor response to antihypertensive medications. [5] [6] [7] [21] [22] [23] However, the optimal protocol for determining which patients have an elevated BP in the office setting remains unclear. 23 Our CFA yielded some interesting findings that can inform recommendations for office BP measurement protocols in clinical practice. First, with respect to number of readings, our analysis revealed that clinicians gain more confidence in office measurements from increasing the number of visits with readings than from increasing the number of readings per visit, consistent with Rosner and Polk's prior investigation of this question. 24 Further, there are diminishing returns from increasing the number of BP measurements beyond 2 or 3 per visit, or for increasing the number of visits beyond 2. These findings reinforce the recommendations by the American Society of Hypertension to estimate office BP by averaging BP readings from 2 consecutive office visits. 25 Our CFA model also showed that dropping the first manual BP reading within a visit, as is recommended by some guidelines, had no benefit in terms of increasing the confidence of BP classifications, and even slightly decreased the probability of the measured office systolic BP being close to the "true" office BP for oscillometric measurements. 6 In the case of manual BP measurements, the benefit of preventing the upward bias attributable to the initial reading by dropping the first manual BP reading was counterbalanced by the loss of reliability from having fewer total readings with the first one excluded. The finding for oscillometric measurements may be due to the fact that they were taken after the manual measurements, and therefore there was no tendency for the first oscillometric reading to be elevated, and hence no benefit from dropping this reading. Our CFA also demonstrated that there were minimal differences in the confidence of BP estimates obtained by manual mercury vs. oscillometric devices when both are measured using rigorous, guideline-concordant standards. However, it is important to recognize that prior studies have shown that in routine clinical practice, oscillometric BP measurements are usually more accurate than manual measurements as the automated oscillometric devices are less susceptible to human errors such as digit rounding and rapid cuff deflation. 26, 27 Finally, we learned that one cannot gain high confidence that office systolic BP is non-elevated among individuals with average systolic BP just below the 140/90 mm Hg cutpoint (e.g., 137-139 mm Hg), even after averaging multiple readings across multiple visits.
Our findings provide support for recommendations to measure BP at least twice across 2 visits to confidently diagnose hypertension. 7 However, in healthy patients who have few reasons to return for office visits, measuring BP 2 or 3 times within a single visit may be the most efficient, patientcentered strategy for determining who should be referred for out-of-office BP testing, as even with return visits, a substantial number of patients with average BP readings near the cutpoint for classifying BP will still have an indication for out-of-office BP testing.
Although one prior study has examined the number of BP readings needed to confidently classify BP status, to our knowledge our study is the first to empirically examine this question in patients being screened for hypertension. 28 The finding that out-of-office BP readings may be indicated for patients slightly below the cutpoint used to diagnose hypertension represents a significant change from the usual recommendations for referral to out-of-office BP testing during hypertension screening.
These findings must be interpreted in the context of several possible limitations. First, all BPs were measured by trained nurses carefully adhering to a measurement protocol under no time pressure. Hence, the application of these findings to BPs measured in usual practice must be made with caution. Nevertheless, guidelines recommend that clinicians strive for high-quality clinic assessments. Second, one of the aims of this study was to compare manual and oscillometric Although the data for this analysis were taken from blood pressure (BP) readings from 3 office visits, once specified, the model can provide probability estimates of correct classification of office BP based on an even larger number of visits and readings. Accordingly, the figure shows estimates for the probability of correct classification of office BP for BP measurement protocols with more than 3 visits.
methods. In the study protocol, manual readings were always taken prior to automatic readings, and this prevented any impact of an alerting response during initial readings on automatic readings. Other limitations included the absence of participants with initial screening systolic BP >160 mm Hg, inclusion of only a limited number of elderly participants, and the exclusion of patients with known cardiovascular disease or other serious medical conditions, thereby limiting the ability to extrapolate our results to these groups. Also, we did not compare our office BP measurements with out-of-office BP measures as our goal was to compare protocols for measuring office BP. Hence, conclusions about the extent to which office BP readings correspond to goldstandard out-of-office assessments cannot be made from the present analysis. 29 Nevertheless, office BP measurement approaches are still needed to determine who should be referred for out-of-office testing, and office BP measurement still represents the predominant approach to BP measurement and hypertension diagnosis in clinical practice. 30, 31 Finally, there are emerging data supporting the use of unattended office BP measurements, and this approach was not compared in our study. 32 
PERSPECTIVES
In summary, we used a state-of-the-art modeling approach to compare the confidence gained in classifying office BP by different approaches to office BP measurement. We learned that averaging one BP reading across 2 visits may best balance maximizing accuracy with efficiency of measurement during hypertension screening, though the exact recommended protocol may vary with the clinical context. These findings can be used to inform the development of office BP measurement protocols and to guide the indications for referring patients for ambulatory or home BP monitoring as part of hypertension screening.
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